Acciones Beleave Inc. Canadian Securities Exchange
Acciones
BE
CA0775611084
Farmacéuticos
Ventas 2018 | - | Ventas 2019 | 2,37 3,23 2,18 | Capitalización | 30,37 M 41,37 M 27,94 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -12 M -16,35 M -11,04 M | Resultado Neto 2019 | -33 M -44,96 M -30,36 M | VE / Ventas 2018 | - |
Posición de caja neta 2018 | 5,2 M 7,09 M 4,79 M | Deuda neta 2019 | 10,32 M 14,05 M 9,49 M | VE / Ventas 2019 | 17.137.012 x |
P/E ratio 2018 |
-4,72
x | P/E ratio 2019 |
-0,76
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 98,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+45,15 % | 6383,68 M | |
-14,00 % | 4589,76 M | |
+9,54 % | 3390,04 M | |
-8,99 % | 3204,32 M | |
-2,41 % | 2518,07 M | |
+50,03 % | 2004,48 M | |
-6,97 % | 1701,92 M | |
-0,31 % | 1645,9 M | |
-10,61 % | 1576,56 M |